About this trial
This prospective randomized controlled study aims to compare the effects of Serratus Posterior Superior Intercostal Plane (SPSIP) block and Rhomboid Intercostal and Subserratus (RISS) block on postoperative pain, respiratory function, and recovery quality in patients undergoing volume-preserving video-assisted thoracoscopic surgery (VATS). Eighty-four patients will be randomized in a 1:1 ratio to receive either SPSIP block or RISS block. The primary outcome is the incidence of somatic pain at the chest drain insertion site at postoperative 2 hours. Secondary outcomes include pain scores, opioid consumption, quality of recovery, diaphragmatic function, pulmonary function, rescue analgesic requirements, postoperative nausea and vomiting, and block-related complications.
Eligibility criteria
Qualifiers
Patients scheduled for elective biportal video-assisted thoracoscopic surgery (VATS) with lung parenchyma-preserving thoracic procedures under general anesthesia
American Society of Anesthesiologists (ASA) physical status I-III
Age between 18 and 75 years
Provision of written informed consent
Disqualifiers
Use of anticoagulant or antiplatelet therapy
Bleeding diathesis
Known allergy to local anesthetics
Infection at the planned block site
Trial design
Treatments tested in this trial
- Serratus posterior superior intercostal plane block
- Rhomboid Intercostal and Subserratus Block
Treatment groups
Sponsors and collaborators
Ferit Yetik
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Sponsor institution
Bursa Sehir Hastanesi
Collaborator